FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.
The importance of breast cancer screening
October is Breast Cancer Awareness Month. Breast cancer is the second-leading cause of cancer deaths in women across the U.S. And rates of the disease continue to climb, notably among younger women. A report from the American Cancer Society calculates that one in 50 women will develop invasive breast cancer by the age of 50.
Experimental drug RK-33 shows promise in treating breast cancer bone metastasis
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists
(MedPage Today) — Treatment with GLP-1 receptor agonists was associated with lower risks of suicidal ideation or attempts in adolescents with obesity compared with those who were treated with lifestyle interventions, a retrospective cohort study…
GLP-1 weight-loss meds won’t raise teens’ suicide risk, may even lower it
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
New way to kill cancer cells could lead to longer lasting protection for people with breast cancer
Killing breast cancer cells in a way that trains the immune system to recognize and destroy residual cancer cells could offer longer lasting protection to people with the disease.
Jill Martin urges awareness of breast cancer genetic testing on ‘Football Night in America’
TODAY contributor Jill Martin was diagnosed Stage 2 breast cancer in 2023 after she learned she had a BRCA gene mutation, which increases a woman’s risk of developing breast cancer by 60-90%. Had she not been tested for the mutation, her cancer could’ve progressed further, and Jill, now cancer-free, may have had a very different prognosis. Jill urged viewers to learn whether they should undergo genetic testing for breast cancer ahead of the Giants-Bengals game on Oct. 13’s ‘Football Nigh
How to decide which breast cancer surgery is right for you
Women diagnosed with breast cancer are almost immediately confronted with treatment decisions. If a surgical oncologist gave a choice between a lumpectomy and a mastectomy to remove a tumor, that’s often because either option will lead to a similar long-term health outcome.
Cheap Ozempic knock-offs have risen in popularity — but are they safe?
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.